Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
T.PYR: Contract Toward Titanium Powder Supply & Distribution Agreement with Asian Materials Co. (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Dancann Pharma AS (GM) DCPXF

Healthcare Drug Manufacturers - Specialty & Generic
DanCann Pharma A/S, a biopharmaceutical company, focuses on commercializing new therapeutic cannabinoids in various disease areas. The company distributes prescription cannabinoid-based medicines. It develops EXT03 CannGros, an oral extract based on Bediol; EXT04 CannGros, an oral extract based on Bedrolite; EXT02 CannGros, an oral extract based on Bedrocan; FLS04 CannGros granulate; FLS05... see more

Current News (GREY:DCPXF)

DanCann Pharma A/S publishes Q2-2023 report

PR Newswire August 31, 2023

DanCann Pharma A/S publishes Q1-2023 report

PR Newswire May 31, 2023

DanCann Pharma A/S publishes Annual Report 2022

PR Newswire May 12, 2023

DanCann Pharma A/S publishes Q4-2022 report

PR Newswire February 28, 2023
View More News ››

Opinion & Analysis (GREY:DCPXF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (GREY:DCPXF)

Be the first to post on this bullboard.

New Pacific Metals Corp

New Pacific Metals Corp

New Pacific Metals Corp., together with its subsidiaries, engages in the exploration and development of mineral properties in ...
View More »

Podcasts